Search results
Private biotech M&A surges amid difficult IPO market
BioPharma Dive· 6 days agoPrivate biotech company acquisitions are on their fastest pace in years, a trend some in the industry say is driven by the abundance of mature, but not...
Private biotech company acquisitions are on their fastest pace in years, a trend some in the industry say is driven by the abundance of mature, but not...